311 related articles for article (PubMed ID: 21089772)
1. Monte Carlo calculated TG-60 dosimetry parameters for the beta- emitter 153Sm brachytherapy source.
Sadeghi M; Taghdiri F; Hosseini SH; Tenreiro C
Med Phys; 2010 Oct; 37(10):5370-5. PubMed ID: 21089772
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo characterization of biocompatible beta-emitting 90Y glass seed incorporated with the radionuclide 153Sm as a SPECT marker for brachytherapy applications.
Hadadi A; Sadeghi M; Sardari D; Khanchi A; Shirazi A
J Appl Clin Med Phys; 2013 Sep; 14(5):90-103. PubMed ID: 24036862
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric aspects of 166Ho brachytherapy biodegradable glass seed.
Hosseini SH; Enferadi M; Sadeghi M
Appl Radiat Isot; 2013 Mar; 73():109-15. PubMed ID: 23313765
[TBL] [Abstract][Full Text] [Related]
4. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
5. The use of cylindrical coordinates for treatment planning parameters of an elongated 192Ir source.
Patel NS; Chiu-Tsao ST; Fan P; Tsao HS; Liprie SF; Harrison LB
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1093-102. PubMed ID: 11704334
[TBL] [Abstract][Full Text] [Related]
6. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric characteristics of a linear array of gamma or beta-emitting seeds in intravascular irradiation: Monte Carlo studies for the AAPM TG-43/60 formalism.
Ye SJ; Parsai EI; Feldmeier JJ
Med Phys; 2003 Mar; 30(3):403-14. PubMed ID: 12674241
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo simulations and radiation dosimetry measurements of 142Pr capillary tube-based radioactive implant (CTRI): a new structure for brachytherapy sources.
Bakht MK; Sadeghi M; Ahmadi SJ; Haddadi A; Sadjadi SS; Tenreiro C
Ann Nucl Med; 2013 Apr; 27(3):253-60. PubMed ID: 23381937
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Meigooni AS; Sowards K; Soldano M
Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
[TBL] [Abstract][Full Text] [Related]
10. A new treatment planning formalism for catheter-based beta sources used in intravascular brachytherapy.
Patel NS; Chiu-Tsao ST; Tsao HS; Harrison LB
Cardiovasc Radiat Med; 2001; 2(3):157-64. PubMed ID: 11786322
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo dose calculations of beta-emitting sources for intravascular brachytherapy: a comparison between EGS4, EGSnrc, and MCNP.
Wang R; Li XA
Med Phys; 2001 Feb; 28(2):134-41. PubMed ID: 11243335
[TBL] [Abstract][Full Text] [Related]
14. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
15. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
Selvam TP; Sahoo S; Vishwakarma RS
Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric characteristics of the ¹⁹²Ir high-dose-rate afterloading brachytherapy source.
Sadeghi M; Taghdiri F; Saidi P
Jpn J Radiol; 2011 Jun; 29(5):324-9. PubMed ID: 21717300
[TBL] [Abstract][Full Text] [Related]
17. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Proposed Biodegradable 188Re Source for Brachytherapy Application: A Review of Dosimetric Parameters.
Khorshidi A; Ahmadinejad M; Hamed Hosseini S
Medicine (Baltimore); 2015 Jul; 94(28):e1098. PubMed ID: 26181543
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
